XNK Therapeu cs AB (“XNK”) today announced that Linda Brick, Head of QA, will be speaking at the 8 th CAR- TCR Summit in Boston. The annual CAR-TCR Summit is the world’s pre …
Dr. David Berglund and Dr. Stephen Wooding nominated as new …
XNK Therapeutics AB (“XNK”) today announced that Dr. David Berglund and Dr. Stephen Wooding are proposed to be appointed members of the Board of Directors. The decision will …
XNK Therapeutics to present at 2[nd] Annual Innate Killer Europe …
2023年10月5日 · XNK Therapeutics AB today announced that Anna-Karin Maltais, Chief Scientific Officer, will be speaking at the 2[nd] Annual Innate Killer Europe Summit in London on October …
Integritetspolicy avseende aktieägare – XNK Therapeutics
I denna integritetspolicy redogörs närmare för hur XNK Therapeutics AB (”Bolaget”) behandlar personuppgifter om dig i din egenskap av aktieägare eller representant för aktieägare eller …
XNK Therapeutics strengthens its scientific network with two more ...
XNK Therapeutics AB (“XNK”) today announced the appointment of Dr. Gunilla Enblad, Professor of oncology at Uppsala University, and Dr. Rizwan Romee, Associate Professor of Medicine at …
XNK Therapeutics partners with Cellect for next generation …
2020年12月11日 · XNK Therapeutics AB (“XNK”) announces its collaboration agreement with Israel-based Cellect Biotechnology (“Cellect”) to develop the next generation version of XNK’s …
KALLELSE TILL ÅRSSTÄMMA I XNK THERAPEUTICS AB
Aktieägarna i XNK Therapeutics AB (publ), org.nr 556894–6601, kallas härmed till årsstämma tisdagen den 13 juni 2023 kl. 17.00 i bolagets lokaler, Novum, plan 8 (hiss E), Hälsovägen 7, …
Agneta Edberg appointed to board of XNK Therapeutics
2018年5月7日 · XNK Therapeutics AB (“XNK”) today announced it strengthened its organization by appointing Agneta Edberg to the board of directors. Agneta Edberg has over 25 years’ …
XNK Therapeutics AB (“XNK”) today announced that the company’s autologous natural killer (NK) cell therapy candidate XNK04 will be evaluated in combination with an ADCC competent PD …
XNK Therapeutics to present at ABGSC Private Companies Seminar …
2021年12月1日 · XNK Therapeutics AB’s CEO, Johan Liwing, will present at the ABGSC Private Companies event on December 6. The presentation starts at 09:30CET and will be …